Cargando…
Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307049/ https://www.ncbi.nlm.nih.gov/pubmed/37388370 http://dx.doi.org/10.1155/2023/9765065 |
| _version_ | 1785065955651485696 |
|---|---|
| author | International, BioMed Research |
| author_facet | International, BioMed Research |
| author_sort | International, BioMed Research |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10307049 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103070492023-06-29 Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway International, BioMed Research Biomed Res Int Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307049/ /pubmed/37388370 http://dx.doi.org/10.1155/2023/9765065 Text en Copyright © 2023 BioMed Research International. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction International, BioMed Research Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway |
| title | Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway |
| title_full | Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway |
| title_fullStr | Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway |
| title_full_unstemmed | Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway |
| title_short | Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway |
| title_sort | retracted: dapagliflozin improves diabetic cardiomyopathy by modulating the akt/mtor signaling pathway |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307049/ https://www.ncbi.nlm.nih.gov/pubmed/37388370 http://dx.doi.org/10.1155/2023/9765065 |
| work_keys_str_mv | AT internationalbiomedresearch retracteddapagliflozinimprovesdiabeticcardiomyopathybymodulatingtheaktmtorsignalingpathway |